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Abstract
Background:	 Few	 case	 reports	 and	 clinical	 series	 exist	 on	 pregnant	women	 infected	
with	SARS-	CoV-	2	who	delivered.
Objective:	To	review	the	available	information	on	mode	of	delivery,	vertical/peripartum	
transmission,	and	neonatal	outcome	in	pregnant	women	infected	with	SARS-	CoV-	2.
Search strategy:	Combination	of	the	following	key	words:	COVID-	19,	SARS-	CoV-	2,	and	
pregnancy	in	Embase	and	PubMed	databases.
Selection criteria:	Papers	reporting	cases	of	women	infected	with	SARS-	CoV-	2	who	delivered.
Data collection and analysis:	The	following	was	extracted:	author;	country;	number	of	
women;	study	design;	gestational	age	at	delivery;	selected	clinical	maternal	data;	mode	
of	delivery;	selected	neonatal	outcomes.
Main results:	In	the	13	studies	included,	vaginal	delivery	was	reported	in	6	cases	(9.4%;	
95%	CI,	3.5–19.3).	Indication	for	cesarean	delivery	was	worsening	of	maternal	condi-
tions	in	31	cases	(48.4%;	95%	CI,	35.8–61.3).	Two	newborns	testing	positive	for	SARS-	
CoV-	2	by	real-	time	RT-	PCR	assay	were	reported.	In	three	neonates,	SARS-	CoV-	2	IgG	
and	IgM	levels	were	elevated	but	the	RT-	PCR	test	was	negative.
Conclusions:	The	rate	of	vertical	or	peripartum	transmission	of	SARS-	CoV-	2	is	low,	if	any,	
for	cesarean	delivery;	no	data	are	available	for	vaginal	delivery.	Low	frequency	of	spon-
taneous	preterm	birth	and	general	favorable	immediate	neonatal	outcome	are	reassuring.
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1  | INTRODUCTION
Midwives	and	obstetricians	face	a	new	challenge	posed	by	the	recent	
outbreak	of	COVID-	19.	 In	 this	early	phase	of	 the	epidemic,	 few	data	
are	available	on	the	effect	of	COVID-	19	on	pregnant	women.	The	risk	
of	intrauterine	and	peripartum	transmission	of	the	virus	to	the	fetus	is	
also	largely	unknown.
Until	now,	most	of	the	guidelines	are	based	on	previous	experience	
with	other	highly	pathogenic	coronaviruses,	namely	severe	acute	respira-
tory	syndrome	(SARS)	and	Middle	East	respiratory	syndrome	(MERS).1–3
A	recent	consensus	stated	that	there	is	no	clear	evidence	on	tim-
ing	of	optimal	delivery,	 safety	of	vaginal	delivery,	or	whether	 cesar-
ean	 delivery	 prevents	 vertical	 transmission	 at	 the	 time	 of	 delivery.	
Therefore,	mode	and	timing	of	delivery	should	be	individualized	based	
on	obstetric	indications	and	maternal–fetal	status.2
During	 recent	weeks,	 some	case	 reports	and	clinical	 series	have	
been	 published	 on	mode	 of	 delivery,	 immediate	 neonatal	 outcome,	
risk	of	infection	of	the	newborn,	and	breastfeeding	in	pregnant	women	
infected	with	COVID-	19.4–6	These	series,	although	of	few	cases,	may	
offer	initial	information	to	direct	clinical	practice.
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The	aim	of	 the	present	article	was	to	 review	the	available	 infor-
mation	with	 special	 focus	 on	mode	 of	 delivery,	 vertical/peripartum	
transmission,	 and	 immediate	neonatal	 outcome	of	 pregnant	women	
infected	with	SARS-	CoV-	2.
2  | MATERIALS AND METHODS
We	 searched	 PubMed	 (National	 Library	 of	 Medicine,	 Washington,	
DC)	and	Embase	(Elsevier)	databases	from	January	1	up	to	March	31,	
2020,	 using	 a	 combination	 of	 the	 following	 key	words:	 COVID-	19,	
SARS-	CoV-	2,	and	pregnancy.	We	also	reviewed	the	reference	lists	of	
retrieved	articles	to	search	for	other	pertinent	studies.	Two	authors	
(FP	and	RB)	reviewed	the	papers	and	independently	selected	the	arti-
cles	eligible	for	systematic	review.	Studies	were	selected	if	they	met	
the	following	criteria:	clinical	studies,	studies	reporting	original	data,	
studies	reporting	SARS-	CoV-	2	infected	women	who	delivered.
2.1 | Data extraction
A	PICOS	(Patient,	Intervention,	Comparator,	Outcome,	Study)	design	
structure	was	used	to	develop	the	study	questions	and	the	inclusion/
exclusion	 criteria.	The	question	was:	 “What	 is	 the	mode	of	delivery	
and	the	obstetric	and	 immediate	neonatal	outcomes	 in	SARS-	CoV-	2	
infected	pregnant	women?”	(Table	1).
For	 each	 study,	 the	 following	 information	 was	 extracted:	 first	
author's	 last	name;	year;	country;	number	of	women	who	delivered;	
study	 design;	 gestational	 age	 at	 delivery;	 selected	 clinical	 maternal	
data	(maternal	age,	comorbidity,	diagnosis	of	pneumonia,	treatment);	
mode	of	delivery;	selected	neonatal	outcomes	(birthweight,	5-	minute	
Apgar	score,	admission	to	neonatal	intensive	care	unit	[NICU]	neona-
tal	diseases;	SARS-	CoV-	2	positivity).
2.2 | Data synthesis
The	 primary	 outcomes	 assessed	 were	 frequency	 of	 preterm	 birth	
(<37	 weeks	 of	 gestation),	 vaginal	 delivery,	 Apgar	 score	 at	 5	 min-
utes	 <7,	 and	 newborn	 infection.	 For	 each	 study	 with	 binary	 out-
comes,	 we	 calculated	 the	 95%	 confidence	 intervals	 (CIs)	 of	 the	
estimated	proportion.
3  | RESULTS
The	 initial	search	retrieved	41	abstracts	 from	PubMed	and	23	from	
Embase.	 After	 exclusion	 of	 unrelated	 abstracts	 of	 review	 papers,	
guidelines,	 and	 commentaries,	 17	 papers	 were	 selected	 for	 exten-
sive	review.	Two	studies	reported	data	only	on	maternal	outcome.7,8 
Another	 paper	 was	 published	 without	 peer	 review.9	 One	 study	
was	 published	 in	 Chinese.10	 Therefore,	 a	 total	 of	 13	 studies	 were	
included.4–6,11–20	Table	2	presents	their	main	methodological	charac-
teristics.	Six	studies	were	case	reports	and	seven	were	retrospective	
clinical	series.
A	total	of	64	pregnant	women	who	delivered	were	reported	in	the	
studies	(seven	women	admitted	to	hospital	but	who	did	not	deliver	at	
the	time	of	publication	were	also	reported).
Table	3	presents	the	maternal	characteristics	and	clinical	condi-
tions.	Pneumonia	was	present	in	49/61	(80.3%;	95%	CI,	68.2–89.4)	
cases	for	which	the	 information	was	available.	For	cases	with	avail-
able	information,	oxygen	support	was	needed	by	29/35	(82.9%;	95%	
CI,	66.4–93.4)	and	2/31	(6.5%;	95%	CI,	0.8–2.4)	were	admitted	to	a	
critical	care	unit	(CCU).
Table	4	presents	mode	of	delivery	data.	Vaginal	delivery	was	reported	
in	 six	 (9.4%)	 cases	 (95%	 CI,	 3.5–19.3).	 Indication	 for	 cesarean	 deliv-
ery	was	worsening	of	maternal	 conditions	 in	 31	women	 (48.4%;	 95%	
CI,	35.8–61.3;	 cases	 reported	by	Liu	et	al.14	 and	Zeng	et	al.19	 are	not	
included	since	the	indication	for	cesarean	section	was	unclear	in	the	text.
Preterm	birth	(<37	weeks	of	gestation)	was	observed	in	19	cases	
among	the	48	for	which	the	information	on	gestational	age	at	delivery	
was	available	(39.6%;	95%	CI,	25.8–54.7).	In	only	two	cases,	reported	
by	Zhu	et	al.,5	delivery	was	due	to	spontaneous	preterm	labor	(1	twin	
pregnancy	and	1	premature	rupture	of	membranes).
Table	5	presents	data	on	the	immediate	neonatal	outcome	and	the	
frequency	of	SARS-	Cov-	2	positivity	in	the	newborns.	Low	birthweight	
(<2500	 g)	was	 observed	 in	 10	 newborns	 (10/37	 [27.0%]	 for	which	
information	was	available;	95%	CI,	13.8–44.1).	In	all	cases,	5-	minute	
Apgar	score	was	greater	than	7.	One	neonatal	death	due	to	dissem-
inated	 intravascular	 coagulation	 (DIC)	 syndrome	was	 reported.	 The	
death	occurred	in	a	singleton	male	neonate	born	by	cesarean	delivery	
at	34	+	5	weeks	of	gestation	and	weighing	2200	g.	The	cause	of	death	
was	multiple	organ	failure	and	DIC.
Considering	 respiratory	disease	 in	 newborns,	 one	 case	of	 pneu-
monia,	 one	 low-	grade	 fever	 and	 haziness	 in	 both	 lung	 fields,	 one	
high-	density	nodular	 shadow	under	 the	pleura	of	 the	 right	 lung,	 six	
shortness	 of	 breath,	 and	 two	 cases	 of	 neonatal	 respiratory	 distress	
syndrome	were	reported.
Wang	et	al.16	reported	a	case	of	neonatal	COVID-	19	infection	with	
pharyngeal	 swabs	 testing	positive	by	 rRT-	PCR	 assay	36	hours	 after	
cesarean	 delivery;	whether	 the	 case	 is	 a	 vertical	 transmission	 from	
mother	to	child	remains	to	be	confirmed.
Dong	et	al.11	reported	a	case	of	a	neonate	delivered	by	cesarean	
in	which	SARS-	CoV-	2	IgG	and	IgM	levels	were	elevated	at	2	hours	old.	
TABLE  1 PICOS	criteria	for	inclusion	and	exclusion	of	studies.
Parameter Inclusion criteria Data extraction
Patient Women	treated	
for	SARS-	CoV-	2	
infection
Location,	age,	clinical	
characteristics
Intervention Delivery Mode	of	delivery
Comparator None
Outcome Neonatal	outcome Birth	weight,	Apgar	score,	
neonatal	disease,	NICU	
admission,	SARS-	CoV-	2	
positivity
Study Case	reports/observa-
tional	studies
Type	of	study	design
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Results	from	five	RT-	PCR	tests	on	nasopharyngeal	swabs	taken	from	
2	hours	to	16	days	old	were	negative.	Two	other	newborns	delivered	
by	cesarean	with	elevated	 IgM	antibodies	 to	SARS-	CoV-	2	virus,	but	
negative	 throat	 swab	 result	 by	 RT-	PCR	 have	 also	 been	 reported.19 
Finally,	Yu	 et	 al.17	 reported	 the	 case	 of	 a	 RT-	PCR	positive	 test	 in	 a	
newborn	36	hours	after	cesarean	birth.
4  | DISCUSSION
The	results	of	this	fast	review	of	the	available	data	on	mode	of	deliv-
ery	 and	 immediate	 neonatal	 outcome	 in	 pregnant	 women	 infected	
with	SARS-	CoV-	2	suggest	that	the	risk	of	vertical	or	peripartum	trans-
mission	of	the	virus	to	the	newborn	is	limited,	if	any.
TABLE  2 Study	characteristics	and	sample	size	of	the	studies	included	in	the	review.
Authors, year, country Type of study Aim Assessment Cases (No.)
Chen	et	al.,	2020,	China4 Retrospective	clinical	series IVT AF,	CB,	ITS,	M 9
Chen	et	al.,	2020,	China20 Retrospective	clinical	series — — 5
Dong	et	al.,	2020,	China11 Case	report IVT IGM-	IGG,	INPS,	M,	VS 1
Fan	et	al.,	2020,	China12 Case	report IVT AF,	CB,	IGG,	INPS,	M,	PT,	VS 2
Lee	et	al.,	2020,	Korea18 Case	report IVT AF,	CB,	INPS,	PT 1
Li	et	al.,	2020,	China13 Case	report IVT AF,	CB,	IB,	IOPS,	IS,	IU,	M,	PT 1
Liu	et	al.,	2020,	China14 Retrospective	clinical	series IVT Nr 10/+3a
Liu	et	al.,	2020,	China15 Retrospective	clinical	series — — 11/+4a
Wang	et	al.,	2020,	China16 Case	report IVT CB,	IOPS,	M,	PT 1
Wang	et	al.,	2020,	China6 Case	report IVT AF,	CB,	IGJ,	IS,	ITS,	PT 1
Yu	et	al.,	2020,	China17 Retrospective	clinical	series — — 7
Zeng	et	al.,	2020,	China19 Retrospective	clinical	series IVT IB,	IGM-	IGG,	ITS 6
Zhu	et	al.,	2020,	China5 Retrospective	clinical	series IVT IOPS 9b
Abbreviations:	 IVT,	 intrauterine	vertical	transmission;	AF,	amniotic	fluid;	CB,	cord	blood;	 ITS,	 infant	throat	swab;	M,	milk;	 INPS,	 infant	nasopharyngeal	 
swab;	PT,	placenta	tissues;	VS,	vaginal	swab;	IOPS,	infant	oropharyngeal	swab;	IB,	infant	blood;	IS,	infant	stool;	IU,	infant	urine;	IGJ,	infant	gastric	juice;	 
Nr,	not	reported.
aPatients	with	pregnancy	in	progress.
bNine	mothers	and	10	neonates.
TABLE  3 Maternal	characteristics	and	clinical	conditions	of	the	women	in	the	included	studies.
Authors Maternal age, y Comorbidities Antiviral therapy Pneumonia Oxygen support CCU admission
Chen	et	al.4 26–40 2	GH/9 6/9 9/9 9/9 0a/9
Chen	et	al.20 25–31 2GD,	1GH/5 5c/5 5b/5 0/5 Nr
Dong	et	al.11 29 0/1 1/1 1b/1 1/1 Nr
Fan	et	al.12 29,	34 0/2 2/2 2/2 Nr Nr
Lee	et	al.18 28 0/1 0/1 1/1 0/1 0/1
Li	et	al.13 30 0/1 1/1 1b/1 Nr Nr
Liu	et	al.14 22–36 0/13 Nr 1/13 Nr 1/13
Liu	et	al.15 23–40	(mean,	SD,	
32	+−	5)
1 GD, 1VR/11 11c/11 11/11 11/11 Nr
Wang	et	al.16 34 0/1 1c/1 1b/1 Nr Nr
Wang	et	al.6 28 0/1 1/1 1/1 1/1 1/1
Yu	et	al.17 29–34	(mean	32) 2d/7 7/7 7/7 7/7 0/7
Zeng	et	al.19 Nr Nr Nr Nr Nr Nr
Zhu	et	al.5 25–35	(mean	30) 0/9 3c/9 9/9 Nr Nr
Abbreviations:	CCU,	critical	care	unit;	GH,	gestational	hypertension;	GD,	gestational	diabetes;	VR,	mitral	and	tricuspid	valve	replacement;	Nr,	not	reported.
aNo	mechanical	ventilation.
bComputed	tomography	scan	with	typical	images	of	viral	pneumonia.
cAfter	delivery.
d1	hypothyroidism,	1	polycystic	ovary	syndrome.
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We	 identified	 two	 cases	 of	 newborn	 infection,	 confirmed	 posi-
tive	by	rRT-	PCR	assay,	out	of	64	reported	cases.	To	our	knowledge,	
another	case	of	a	newborn	infected	with	SARS-	CoV-	2	(not	included	in	
this	review)	has	been	reported	by	the	National	Health	Commission	of	
the	People's	Republic	of	China,21,22	in	which	the	diagnosis	was	made	
at	17	days	of	life.	In	all	cases,	postpartum	neonatal	infection	acquired	
through	an	infected	contact	was	impossible	to	exclude.
IgM	 antibodies	 to	 SARS-	CoV-	2	 were	 found	 in	 three	 cases.11,19 
Caution	in	interpreting	these	findings	has	been	suggested,	including	the	
possibility	that	IgM	positivity	could	represent	a	laboratory	artifact.23
These	 findings	 suggest	 that	 transmission	 in	 utero	 is	 possible.	
However,	SARS-	CoV-	2	was	not	found	in	amniotic	fluid	or	cord	blood	
and	this	finding	is	based	on	very	few	cases.5
Data	 on	 virus	 transmission	 are	 based	 substantially	 on	women	
who	delivered	by	cesarean.	This	aspect	 is	relevant.	 In	fact,	vertical	
transmission	of	 infection	usually	occurs	during	 intrauterine	 life	via	
the	placenta,	or	during	delivery	via	ingestion	or	aspiration	of	cervi-
covaginal	secretions,	and	in	the	postpartum	period	via	breastfeed-
ing.24	The	risk	of	ingestion	or	aspiration	of	cervicovaginal	secretions	
or	contact	with	perineal	infected	tissue	is	higher	with	vaginal	deliv-
ery.	In	this	review	we	identified	19	women	who	delivered	preterm,	
although	 spontaneous	 vaginal	 preterm	 birth	was	 reported	 in	 only	
two	cases.	Therefore,	 there	 is	 reassuring	evidence	that	COVID-	19	
infection	of	the	mother	did	not	markedly	increase	the	risk	of	spon-
taneous	preterm	birth.
Regarding	maternal	conditions,	we	note	that	COVID-	19	infection	
in	pregnancy	seems	to	be	less	severe	than	other	coronavirus	infections	
such	as	SARS	or	MERS.2,3	We	identified	two	women	who	needed	inten-
sive	care.	The	proportion	of	women	requiring	CCU	admission	seems	
to	 be	 similar	 to	 that	 reported	 in	 the	 general	 population	 affected	 by	
COVID-	19.25	However,	worsening	of	maternal	condition	was	the	cause	
of	emergency	cesarean	delivery	in	about	45%	of	women.	Diabetes	and	
hypertension	are	considered	determinants	of	worse	prognosis	in	cases	
of	infection.25	However,	we	were	unable	to	analyze	this	in	detail;	the	
few	cases	reported	with	diabetes	did	not	need	CCU	admission.
Finally,	 newborn	 outcome	 deserves	 some	 consideration.	 In	 all	
reported	cases	the	5-	minute	Apgar	score	was	greater	than	7	and	generally	
9	or	10	(data	not	shown	in	table).	Furthermore,	the	frequency	of	NICU	
admission	was	low	and	due	to	medically	induced	preterm	birth.	However,	
one	neonatal	death	and	several	cases	of	respiratory	symptoms	or	diseases	
were	 reported	by	pharyngeal	or	nasopharyngeal	swabs,	although	these	
tested	negative	for	SARS-	CoV-	2	by	rRT-	PCR	assay,	except	in	one	case.16
Very	few	reported	cases	provided	information	on	the	risk	of	new-
born	 infection	 during	 breastfeeding.	 Guidelines	 suggest	 allowing	
breastfeeding	 for	 infected	 women	who	wear	 a	 mask.26	 Preliminary	
data	suggest	that	the	virus	is	not	detectable	in	milk.4
In	conclusion,	this	review	of	the	 literature	suggests	that	the	rate	
of	vertical	or	peripartum	transmission	of	SARS-	CoV-	2	is	low,	if	any,	for	
cesarean	delivery.	Crucially,	no	data	were	available	for	vaginal	deliv-
ery.	Likewise,	breastfeeding	was	not	generally	reported;	thus,	the	risk	
TABLE  4 Mode	of	delivery	and	preterm	birth	in	pregnant	women	in	the	included	studies.
Authors Gestational age, w
Mode of delivery
Preterm birth
Cesarean for maternal 
COVID- 19 infection
Cesarean for obstetric 
indication Vaginal delivery
Chen	et	al.4 36–39 9a/9 7a/9 — 4/9
Chen	et	al.20 38–40 — 2/5 3/5 0/5
Dong	et	al.11 37 1/1 — — 0/1
Fan	et	al.12 36,	37 2/2 — — 1/2
Lee	et	al.18 37 — 1/1 0/1
Li	et	al.13 35 — 1b/1 — 1/1
Liu	et	al.14 Nr 5c/10 5d/10 — 6/10
Liu	et	al.15 Nr 9/11 1/11 1/11 Nr
Wang	et	al.16 40 1/1 — — 0/1
Wang	et	al.6 30 1/1 — — 1/1
Yu	et	al.17 37–41 7/7 — — 0/7
Zeng	et	al.19 Nr 6/6g — — Nr
Zhu	et	al.5 31–39 1/9 6e/9 2f/9 6	(2	twins)/10
Abbreviation:	Nr,	not	reported.
aIn	7	cases,	cesarean	delivery	for	maternal	COVID-	19	infection	and	obstetric	indication:	1	history	of	cesarean	delivery,	1	pre-	eclampsia,	2	fetal	distress,	1	
history	of	stillbirth,	2	premature	rupture	of	membranes.
bAlso	fetal	distress.
cNo	obstetric	indication.
d3	fetal	distress,	1	PROM,	1	stillbirth.
e1	premature	rupture	of	membranes,	4	fetal	distress,	1	cholecystitis	and	fever.
f2	premature	rupture	of	membranes,	3	fetal	distress,	2	twins.
gUnclear	in	the	text.
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of	 transmission	during	breastfeeding	 is	 unknown.	 Low	 frequency	of	
spontaneous	preterm	birth	and	generally	favorable	immediate	neona-
tal	outcomes	are	reassuring.
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TABLE  5 Newborn	characteristics	and	breastfeeding.
Authors LBW
5- minute 
Apgar (>7)
NICU 
admission SARS- CoV- 2 (+) Neonatal diseases Breastfeeding
Chen	et	al.4 2/9 9/9 Nr 0/6 0a/9 9/9
Chen	et	al.20 0/5 5/5 Nr 0b/5 0/5 0/5
Dong	et	al.11 0/1 1/1 1c/1 0/1	(1	IgM+	
IgG+/1,INPS-M-VS	- 
IgG+)
— Nr
Fan	et	al.12 0/2 2/2 Nr 0/2 1	low	grade	fever,	haziness	in	both	lung	
fields,	abdominal	distension/1	pneumonia
Nr
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Li	et	al.13 Nr Nr Nr 0/1 0/1 Nr
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